Abstract
Report Description
The Global Biomarker Market report analyzes the biomarker tools and services
market over the period 2009-2014. The report studies the major market drivers,
restraints, and opportunities for the global biomarker market; and also
evaluates the major trends in the macro- and micro-markets with respect to
different geographic regions.
The global biomarker market is estimated to be $20.5 billion by 2014, growing
at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the
biomarkers in the field of drug discovery. The markets for biomarker tools and
services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The
increasing use of biomarkers in clinical services is boosting the overall
biomarker service market.
The high growth of biomarker market is boosted by the demand from the baby
boomer generation in the U.S., and from Asia' s emerging IT industry. Biomarker
applications are increasing in cancer diagnosis as novel tools are being
developed to increase the discovery speed of cancer biomarkers. The use of
proteomics in biomarker testing and identification has in turn boosted the
services for the biomarkers. Market players are now focusing on new product
and service development to enhance their commercial portfolios. Strategic
collaborations among companies are also increasing biomarker applications in
the field of diagnosis and drug discovery.
SCOPE AND FORMAT
The report analyzes the global biomarker market into the following segments:
- Tools Market (pregenomic biomarkers and technologies, postgenomic
biomarkers and technologies, imaging biomarkers, and others)
- Services Market (pre- and post-clinical biomarker services, sample
preparation, mirna analysis, and others)
- Application Market (diagnosis, and drug development and discovery)
The market data consists of aggregate sales figures of all biomarker
submarkets. It analyzes the market aspects of new biomarker technologies and
product launches; sourcing key market developments from the top companies that
it profiles. The report also analyzes the documented claims and the biomarker
technology patents approved over the last five years to provide an in-depth
understanding of biomarker tools and services.
What makes our report unique?
- Provision of longest market segmentation in the industry.
- The report provides analysis of patents and more than 45 company profiles
giving a competitive outlook.
- The report includes market data for segments such as tools, services and
applications for the major geographies - U.S., Europe, Asian and ROW.
- The high level analysis provided by the report analyzes the market
prospective for different major market segments along with the identification
of opportunities.
- Provided competitive analysis stating the major segments focused by the
global market players and the key developments - tools, services and
technology.
|